AstraZeneca’s talks with Bristol Myers Squibb could create the world’s fourth-largest drugmaker by market value
Amelia Pollard is a Reporter at various esteemed publications. She specializes in finance, trading, investment, and white-collar crime, exploring themes such as hedge funds, alternative investments, and corporate fraud. Amelia's work has been featured in Bloomberg News, The Australian Financial Review, Yahoo Finance Canada, and many other prominent outlets.














